Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 1, Issue 4-5, 1999, Pages 231-247

  Jope, R S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acetylcholine; G protein; Postmortem; Protein kinase; amyloid

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MUSCARINIC RECEPTOR; PRESYNAPTIC RECEPTOR;

ALZHEIMER DISEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; PATHOPHYSIOLOGY; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033302310     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1999-14-505     Document Type: Review

References (83)

1. A neurochemical approach for studying response to acetylcholine in Alzheimer's disease
2. 262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
3. Metabolic alterations common to neural and non-neural cells in Alzheimer's disease
4. Phosphoinositide metabolism, aging and Alzheimer's disease
5. Evidence for a selective decrease in type 1 phosphatidylinositol kinase activity in brains of patients with Alzheimer's disease
6. Regulation of phospholipase C-β isozymes by G-proteins
7. Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation
8. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein
9. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease
10. G-protein involvement in central-nervous-system muscarinic-receptor-coupled polyphosphoinositide hydrolysis
11. New roles for G-protein βγ-dimers in transmembrane signalling
12. Characterization and differential distribution of the three major human protein kinase C isozymes (PKCa, PKCb, and PKCγ) of the central nervous system in normal and Alzheimer's disease brains
13. Carbachol and histamine stimulation of guanine-nucleotide-dependent phosphoinositide hydrolysis in rat brain cortical membranes
14. Carbachol in the presence of guanosine 5'-O-(3-thiotriphosphate) stimulates the breakdown of exogenous phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 4-phosphate, and phosphatidylinositol by rat brain membranes
15. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors
16. Decreased levels of protein kinase C in Alzheimer brain
17. β-Amyloid peptides enhance binding of the calcium mobilising second messengers, inositol-(1,4,5)trisphosphate and inositol (1,3,4,5)-tetrakisphosphate to their receptor sites in rat cortical membranes
18. Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's disease
19. Amyloid β protein disruption of cholinergic and growth factor phospholipase C signals could underlie cognitive and neurodegenerative aspects of Alzheimer's disease
20. Cellular and molecular pathology in Alzheimer's disease
21. Area specific alterations in muscarinic stimulated low K(m) GTPase activity in aging and Alzheimer's disease: Implications for altered signal transduction
22. 2 hydrolysis in Alzheimer's disease
23. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease
24. Inositol lipids and signal transduction in the nervous system. An update
25. Contrasting patterns of protein phosphorylation in human normal and Alzheimer brain: Focus on protein kinase C and protein F1/GAP-43
26. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies
27. Brain signal transduction disturbances in neurodegenerative disorders
28. 4 binding in Alzheimer's disease brain
29. Guanine nucleotides stimulate production of inositol trisphosphate in rat cortical membranes
30. Phosphoinositide hydrolysis, Gαq, phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer's disease
31. Protein sequence and mass spectrometric analysis of tan in the Alzheimer's disease brain
32. 3H]phorbol 12,13-dibutyrate binding of protein kinase C in Alzheimer's disease
33. Changes in protein kinases in brain aging and Alzheimer's disease
34. Modulation of carbachol-stimulated inositol phospholipid hydrolysis in rat cerebral cortex
35. Agonist-induced, GTP-dependent phosphoinositide hydrolysis in postmortem human brain membranes
36. 3H]PtdIns hydrolysis in postmortem human brain membranes is mediated by the G-proteins Gq/11 and phospholipase C-β
37. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain
38. Cholinergic activation of the phosphoinositide signal transduction system is impaired in Alzheimer's disease brain
39. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain
40. Alzheimer's disease
41. 3H]Vesamicol binding in human brain cholinergic deficiency disorders
42. Adrenalectomy increases phosphoinositide hydrolysis induced by norepinephrine or excitatory amino acids in rat hippocampal slices
43. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors
44. Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain
45. 356
46. Interaction of cerebral-cortical membranes with exogenously added phosphatidylinositol 4,5-bisphosphate
47. Differential involvement-of protein kinase C isozymes in Alzheimer's disease
48. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease
49. 2+ homeostasis in Alzheimer's disease
50. Robustness of G proteins in Alzheimer's disease: An immunoblot study
51. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
52. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)
53. Release of Alzheimer's amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors
54. Role of neurotransmission in the regulation of amyloid β-protein precursor processing
55. Neuroreceptor changes in Alzheimer disease
56. Alterations of signal transduction in the lesioned entorhinal-hippocampal system: A minireview on Alzheimer's disease-related changes and experimental data
57. Ligand-dependent G protein coupling function of amyloid transmembrane precursor
58. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain
59. Alerations in phosphoinositide signaling and G-protein levels in depressed suicide brain
60. Phosphoinositide signaling in human brain
61. Coupling of ml muscarinic receptors to G protein in Alzheimer's disease
62. Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease
63. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging
64. Tubulin-G protein association stabilizes GTP binding and activates GTPase: Cytoskeletal participation in neuronal signal transduction
65. 262 in fetal tau, adult tau, and paired helical filament tau
66. Changes in signal transduction in Alzheimer's disease
67. Aberrant accumulation of phospholipase C-delta in Alzheimer brains
68. Phosphatidylinositol-specific phospholipase C activity in the postmortem human brain: No alteration in Alzheimer's disease
69. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease
70. Alteration of phospholipase C-δ protein level and specific activity in Alzheimer's disease
71. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease
72. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain - A preliminary study in Alzheimer's disease
73. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq
74. THA-historial aspects, review of pharmacological properties and therapeutic effects
75. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains
76. Activation of the β1 isozyme of phospholipase C by a subunits of the Gq class of G-proteins
77. Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2
78. Transmembrane signaling through phospholipase C in human cortical membranes
79. Effects of Alzheimer's disease-related β amyloid protein fragments on enzymes metabolizing phosphoinositides in brain
80. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients
81. Coupling of muscarinic receptors to GTP-binding proteins in postmortem human brain alterations in Alzheimer's disease
82. In vivo phosphorylation sites in fetal and adult rat tau
83. 3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease